European equities traded in the US as American depositary receipts were lower late Monday morning, falling 1.0% to 1,351.08 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK), which rose 0.8%, followed by accommodations booking company trivago (TRVG) and consumer goods giant Unilever (UL), which were up 0.7% and 0.3% respectively.
The decliners from continental Europe were led by biotech company Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which fell 7.9% and 4.3% respectively. They were followed by medical device maker EDAP TMS (EDAP) and semiconductor company Sequans Communications (SQNS), which were down 4% and 3% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Verona Pharma (VRNA), which increased 5.4% and 2.9% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and telecommunications operator Vodafone Group (VOD), which advanced 2.6% and 1.6% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and biotech company Trinity Biotech (TRIB), which lost 15% and 5.9% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and software development company Endava (DAVA), shed 5.7% and 2.1% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。